About Me
Conditions and Treatments
Conditions
- astigmatism
- blepharitis
- cataract
- conjunctivitis
- corneal disease
- dry eye syndrome
- eye floater
- eye redness
- glaucoma
- hyperopia
- myopia
- ocular herpes
- presbyopia
- refractive error
- stye
- uveitis
Treatments
- eye surgery
Learn more about conditions we treat at NYU Langone:
Cataract , Conjunctivitis , Dry Eye Syndrome , Glaucoma , Refractive Error , StyeCredentials
Positions
- Clinical Assistant Professor, Department of Ophthalmology at NYU Grossman School of Medicine
Board Certifications
- American Board of Ophthalmology - Ophthalmology, 2013
Education and Training
- Fellowship, NA, Corneal Disease, 2013
- Residency, NYU Langone Medical Center, Ophthalmology, 2012
- MD from Northwestern University, 2008
Is this your profile?
Edit profileInsurance Plans Accepted
This provider accepts the following insurance plans.
-
Aetna
- Aetna HMO
- Aetna Indemnity
- Aetna Medicare
- Aetna POS
- Aetna PPO/EPO
-
Cigna
- Cigna EPO/POS
- Cigna PPO
-
Empire Blue Cross Blue Shield
- Empire Blue Cross Blue Shield EPO
- Empire Blue Cross Blue Shield HMO
- Empire Blue Cross Blue Shield Indemnity
- Empire Blue Cross Blue Shield MediBlue
- Empire Blue Cross Blue Shield POS
- Empire Blue Cross Blue Shield PPO
- Empire Blue Cross Blue Shield Pathways, Enhanced
-
HIP
- HIP Access I
- HIP Access II
- HIP Child Health
- HIP EPO/PPO
- HIP HMO
- HIP Medicare
- HIP POS
-
Local 1199
- Local 1199 PPO
-
MagnaCare
- MagnaCare PPO
-
MultiPlan/PHCS
- MultiPlan/PHCS PPO
-
NYS Health Insurance Plan
- The Empire Plan
-
Oxford
- Oxford Freedom
- Oxford Liberty
- Oxford Medicare
-
UHC
- UnitedHealthcare EPO
- UnitedHealthcare HMO
- UnitedHealthcare Medicare
- UnitedHealthcare POS
- UnitedHealthcare PPO
- UnitedHealthcare Top Tier
Jonathan B. Kahn, MD does not accept insurance.
Locations and Appointments
Madison Ophthalmology PLLC
161 Madison Avenue, Suite 5SE, New York, NY 10016
Research Academic Contact
Academic office
161 Madison Avenue, Suite 5-SE
New York, NY 10016
Phone
212-448-0101
Fax
212-448-0116
Clinical Trials and Research Studies
-
A Phase 1/2 First-in-Human Study of DCC-3116 as Monotherapy and in Combination with RAS/MAPK Pathway Inhibitors in Patients with Advanced or Metastatic Solid Tumors with RAS/MAPK Pathway Mutations
-
Randomized multicenter open-label phase 3 study of mirvetuximab soravtansine in combination with bevacizumab versus bevacizumab alone as maintenance therapy for patients with FRa-positive recurrent platinum-sensitive ovarian cancer
-
A Phase 1/1b Open-label Multicenter Study to Investigate the Safety Tolerability Pharmacokinetics Pharmacodynamics and Anti-tumor Activity of KIN-3248 in Participants with Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations
Publications
-
Tauber, Jenna; Chinwuba, Ijeoma; Kleyn, David; Rothschild, Michael; Kahn, Jonathan; Thiel, Cassandra L
JAMA ophthalmology. 2019 Oct 01; 137(10):1156-1163
-
Van Pilsum Rasmussen, S E; Henderson, M L; Kahn, J; Segev, D L
American journal of transplantation. 2017 Oct ; 17(10):2567-2571
-
Charles, Norman C; Kahn, Jonathan B
Ophthalmic plastic & reconstructive surgery. 2017 May/Jun; 33(3S Suppl 1):S33-S34